Evidence map›Paper›PMID 37298194›Full record

ArticleInternational journal of molecular sciences2023

Extracellular Vesicle Depletion Protocols of Foetal Bovine Serum Influence Umbilical Cord Mesenchymal Stromal Cell Phenotype, Immunomodulation, and Particle Release.

Rebecca Davies, Shannen Allen, Claire Mennan, Mark Platt, Karina Wright, Oksana Kehoe

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. An atlas of ferroptosis-induced secretomes.Cell death and differentiation · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rebecca DaviesCentre for Regenerative Medicine Research, School of Medicine (Keele University), RJAH Orthopaedic Hospital, Shropshire SY10 7AG, UK.ORCID 0000-0002-5162-1574
Shannen AllenCentre for Regenerative Medicine Research, School of Medicine (Keele University), RJAH Orthopaedic Hospital, Shropshire SY10 7AG, UK.ORCID 0000-0001-8652-6721
Claire MennanCentre for Regenerative Medicine Research, School of Pharmacy and Bioengineering (Keele University), RJAH Orthopaedic Hospital, Shropshire SY10 7AG, UK.
Mark PlattDepartment of Chemistry, Centre for Analytical Science, Loughborough University, Loughborough LE11 3TU, UK.
Karina WrightCentre for Regenerative Medicine Research, School of Pharmacy and Bioengineering (Keele University), RJAH Orthopaedic Hospital, Shropshire SY10 7AG, UK.
Oksana KehoeCentre for Regenerative Medicine Research, School of Medicine (Keele University), RJAH Orthopaedic Hospital, Shropshire SY10 7AG, UK.ORCID 0000-0002-8702-275X
Keele University · GBLoughborough University · GB

Funding

James Richardson Studentship, Institute of Orthopaedics, Ltd, Oswestry and the UK EPSRC/MRC CDT in Regenerative Medicine EP/F500491/1
6 · The paper itself

Abstract

The immunomodulatory properties of MSCs can be recreated using their extracellular vesicles (EVs). Yet, the true capabilities of the MSC EVs cannot be distinguished from contaminating bovine EVs and protein derived from supplemental foetal bovine serum (FBS). FBS EV depletion protocols can minimise this, but vary in terms of depletion efficiency, which can negatively impact the cell phenotype. We explore the impact of FBS EV depletion strategies, including ultracentrifugation, ultrafiltration, and serum-free, on umbilical cord MSC characteristics. Whilst a greater depletion efficiency, seen in the ultrafiltration and serum-free strategies, did not impact the MSC markers or viability, the MSCs did become more fibroblastic, had slower proliferation, and showed inferior immunomodulatory capabilities. Upon MSC EV enrichment, more particles, with a greater particle/protein ratio, were isolated upon increasing the FBS depletion efficiency, except for serum-free, which showed a decreased particle number. Whilst all conditions showed the presence of EV-associated markers (CD9, CD63, and CD81), serum-free was shown to represent a higher proportion of these markers when normalised by total protein. Thus, we caution MSC EV researchers on the use of highly efficient EV depletion protocols, showing that it can impact the MSC phenotype, including their immunomodulatory properties, and stress the importance of testing in consideration to downstream objectives.

Indexed as

Extracellular VesiclesMesenchymal Stem CellsImmunomodulationSerum Albumin, BovineUmbilical CordSerum Albumin, Bovineextracellular vesiclesimmunomodulationmesenchymal stromal cellsvesicle depletion protocols

Identifiers

PMID37298194
PMCPMC10252846
OpenAlexW4378471051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.